Medirom Healthcare Technologies Inc. (MRM) Cash & Equivalents (2021 - 2025)

Medirom Healthcare Technologies' Cash & Equivalents history runs 5 years deep, the most recent figure standing at $225737.5 for Q2 2025.

• In Q2 2025, Cash & Equivalents fell 75.71% year-over-year to $225737.5; the TTM figure through Jun 2025 stood at $225737.5 (down 75.71% YoY), while the FY2024 annual figure was $2.2 million, up 186.98% from the prior year.
• Cash & Equivalents for Q2 2025 stood at $225737.5, down from $2.2 million in the prior quarter.
• The five-year high for Cash & Equivalents was $4.3 million in Q4 2022, with the low at $225737.5 in Q2 2025.
• The 5-year median for Cash & Equivalents is $929204.2 (2024), against an average of $1.8 million.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents plunged 83.21% in 2023, then surged 201.16% in 2024.
• Medirom Healthcare Technologies' Cash & Equivalents stood at $3.3 million in 2021, then soared by 31.44% to $4.3 million in 2022, then slumped by 83.21% to $719462.2 in 2023, then soared by 201.16% to $2.2 million in 2024, then plunged by 89.58% to $225737.5 in 2025.
• Business Quant data shows MRM's Cash & Equivalents at $225737.5 in Q2 2025, $2.2 million in Q4 2024, and $929204.2 in Q2 2024.